---
$id: https://graph.org.ai/products/commodity/51432807
$type: Product
source: UNSPSC
code: "51432807"
title: "Enalaprilat anhydrous"
class: "51432800"
classTitle: "Antihypertensive oligopeptides"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enalaprilat anhydrous

**UNSPSC Code**: 51432807
**Class**: [Antihypertensive oligopeptides](Antihypertensive oligopeptides.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ace inhibitor with the molecular formula C18H24N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q508Q118JM, chemically known as l-proline, 1-(n-(1-carboxy-3-phenylpropyl)-l-alanyl)-, (s)-, but more generally known as enalaprilat anhydrous, which bears US NIH Compound Identifier 5362033. European Medicines Agency schedules enalaprilat anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06515MIG. Most nations, for tariff purposes, schedule enalaprilat anhydrous under HS 29339990. Enalaprilat anhydrous bears US NLM identifiers UMLS ID C0886809 and NCI Concept Code C76135. SMILES: C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2CCCCC2)C(=O)O.

